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TECHNIQUES based on the anaphylactic response have been used in many
investigations into possible differences between normal and neoplastic tissues.
Maver and Barret (1943) used systemic anaphylaxis along with precipitin and
complement fixation techniques in an attempt to distinguish between cathepsins
of normal and neoplastic tissues. Zilber (1958) and his co-workers employed ana-
phylaxis extensively as an experimental tool. They reported differences betweeni
normal and malignant tissue in rats, mice and rabbits and inferred that the method
demonstrated the existence of tumour-specific antigens. Similar studies were
done on rabbit tumours bv Artamonova (1959), on various human tumours by
Gorodilova and Shershul'skaia (1959), on various tumours of rats and mice by
Levina (1959), on experimental mouse hepatomata by Korosteleva (1959) and on
the Guerin rat epithelioma by Ryzewska (1962).
Makari (1955) went further and postulated that there was an antigen common
to all human carcinomata and that this antigen would be present in the serum of
patients with cancer. He asserted that this antigen could be detected by an
in vitro anaphylactic technique-the Dale-Schultz test. He claimed that, using
the isolated uterine horns of guinea-pigs sensitized with tumour extracts he ob-
tained positive anaphylactic responses with cancer sera after full desensitization
to normal serum, in 96.8% of cases. Burrows (1958) reported similar results, but
less conclusive results were reported by Hackett and Gardonyi (1960), Wittig
et al. (1962) and Maas and Schniewind (1962), while McEwen (1959) obtained
results at variance with Makari's.
It is evident that if Makari's claim were valid, this would be a test of con-
siderable clinical importance. Even if the test gave positive results in a limited
number of cases, as reported by Hackett and Gardonyi, it might still be a useful
investigatory tool in tumour research. Accordingly it was decided to undertake
an evaluation of the applicability of anaphylactic tests to this type of study.
Two tests were investigated: the Dale-Schultz reaction and the measurement of
histamine-release from chopped lung. In the first part of the project (Dale,
1965a and b) it was shown that some of the assumptions on which the use of the
tests was based were invalid. Certain general procedural limits were outlined
within which the tests might possibly be used to analyse antigen mixtures. Using
these limits amock tumourantigenstudywas then carried outto determinewhether.
if a cancer antigen were present in tissue and serum, it could be detected by the
tests (Dale, 1965c). From this latter study it was concluded that the tests might
possibly give positive results if a cancer antigen were either highly antigenic or
else were present in fairly high concentration in both tumour extract and serum.
In the present study two questions were posedANAPHYLACTIC TESTS FOR TUMOUR ANTIGEN
1. Do the test give positive results with the serum of individuals known to be
tumour-bearing?
2. If positive results are obtained, are they specific for neoplasia?
It seemed apparent that the questions could not be definitively answered by
experiments in the clinical field in which many uncontrolled sources of error
exist. A simpler situation with known tumours in laboratory animals was
preferred. Extracts of these tumours were used for sensitization. For the tests
the sera for desensitization were taken from animals of the same strain, sex,
dietary background and age, subjected to the same environmental conditions as
the tumour-bearing animals whose sera were used for challenge.
In the first instance fairly simple experiments on the serum of animals bearing
Walker and Ehrlich tumours were carried out to find out if it was possible to
obtain positive results at all. In these initial experiments a large number of
positive results was obtained suggesting that there was, in fact, antigenic material
in the serum of the tumour-bearing animals which was absent from (or in lower
concentration in) the serum of normal rats and mice. This difference could have
been due to the presence ofa tumour-specific antigen. It could also have been due
to the possibility that the tumours were genetically different from their hosts, and
might therefore release substances into the serum which were immunologically
distinguishable from the hosts' serum proteins but which were not tumour-specific.
A further possible explanation was that the additional antigens were related to
the presence in the body ofrapidly proliferating tissue. In the second part of the
study these two possibilities were investigated. Animals with syngeneic tumours
were used and the serum from these animals (' tumour serum ') was compared with
serum from animals with two other conditions in which rapid non-malignant
proliferation of cells occurs one in which parenchymal cells were involved (liver
regeneration) and one in which connective tissue was involved (sub-acute inflam-
mation).
MATERIAL AND METHODS
Tumour material
The following transmissible tumours were used: solid subcutaneous Ehrlich
carcinoma grown in BALB/c (minus) mice; ascitic Ehrlich carcinoma grown in
BALB/c (minus) mice; Walker carcinoma grown in albino rats; hepatoma grown
in August rats; hepatoma (strain XXIIa) grown in C3HA mice. The first four
tumours were obtained from the Chester Beatty Institute and the fifth from the
Gamaleya Institute in Moscow.
Preparation of tumour extracts
20% extracts of the solid tumours were prepared as described previously for
extracts of normal liver (Dale, 1965c). In the case of ascitic tumours, the ascitic
fluid was frozen and thawed several times to break up any cells present, the
cellular debris was spun down at 3000 r.p.m. and the fluid itself used in sensitiza-
tion. Micro-Kjeldahl estimations of total N content were done on all extracts.
Sensitization procedure
The tumour extract was mixed with an equivalent amount of Freunds ad-
juvants and injected intradermally into 2 sites at the base of the ears in random
bred adult male guinea-pigs.
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Sera used for challenge
In each set of experiments, pooled serum from five or six normal animals of
the requisite strain was used in desensitization procedures. Pooled serum from
tumour-bearing animals was taken from animals other than those whose tumours
were used for sensitization. Serum from animals with normal proliferating tissue
was obtained from animals that had been subjected to partial hepatectomy. In
this latter procedure two-thirds of the liver was removed by the technique of
Higgins and Anderson (1931). Serum was collected 28-30 hours after operation
at about the time of the mitotic peak (Weinbren, 1959). Inflammatory lesions
were made by inducing two large pneumoderma pouches in each animal (Selye.
1953). The irritant used was a mixture of equal parts of turpentine and liquid
paraffin. In mice, 2 ml. air + 0-2 ml. of mixture, and in rats, 10 ml. air + 1 ml.
mixture was used to make each pouch. Serum was collected 3-5 days after the
injection, and pooled.
Dale-Schultz tests
Loops of ileum from the sensitized guinea-pigs were desensitized with normal
serum (NS)-i.e. successive doses of NS were added to the bath until no further
anaphylactic response to NS occurred. The loops were then challenged with one
of the three test sera: tumour serum (CA. 5), serum from animals with partial
hepatectomy (Prolif. S), or serum from animals with inflammatory lesions (Infl. 5)
to determine whether a further anaphylactic response could be obtained. As in
previous experiments (Dale, 1965a), a response to the test serum was only rated
as positive if it was more than 10% of the maximum response possible. In each
case 0.1% or 0 20% serum was used.
Histamine-release test
The basic technique of measurement of histamine-release from chopped lung
has been described by Mongar and Schild (1960). Its application in discrimina-
tion between antigens was discussed in a previous paper (Dale, 1965b). The
principle is that lung tissue from guinea-pigs sensitized with tumour extract is
exposed to normal serum for 20 minutes. Antigen-antibody reactions between the
normal serum constituents and their corresponding antibodies occur and hista-
mine is released. The lung tissue is then exposed to tumour serum or other test
sera to determine whether there is any anaphylactic histamine-release over and
above that produced by normal serum.
In the present study the following experimental protocol was used:
First challenge
Sample (partial Second
numbers desensitization) challenge
Control samples 1, 2, 3, 4 01% NS . 001% NS
5, 6, 7, 8 0.1% NS 01% CA.S
Test samples . 9, 10, 11, 12 0-1% NS . 0-1% Prolif. S
13, 14, 15, 16. 0-1% NS . 0-1% Infl. S
All samples were partially desensitized with 040% NS. Then, after washing,
the histamine-release in the control samples (1, 2, 3, 4) on second challenge with
NS was compared with that in the three sets of test samples on challenge with
CA. 5, Prolif. S or Infl. S. If there was a significant difference between test and
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controlsamplesatthelevelP 0-05, onat-testtheresult wasratedaspositive. (In
the first part ofthe study only one set oftest samples was used instead of 3 sets.)
The sera used were all tested on normal tissue (ileum or lung) in the same
concentrations and found to cause no histamine-release and no Dale-Schultz
reaction.
RESULTS
In the first part ofthe study the question posed was: "Do anaphylactic tests
give positive results with tumour sera? " These experiments were carried out
with Walker and Ehrlich tumours. The results are given in Tables I and II and
may be summarized as follows:
TABLE I.-Histainine-Release Testfor Tumour Antigen
Histamine-release with tumour serum after prior partial desensitization to
normal serum. Each figure is the mean of 3-4 samples. A result is
rated as positive (+) if the difference between test and control samples is
significant at the 5% level.
Histamine-release (as % of total
histamine) in:
Tumour used
Walker tumour in albino rats
Guinea-pig
number
2
3
4
Sub-cutaneous Ehrlich carcinoma in .
BALB/c (minus) mice
1
2
3
4
5
6
7
Control sample
with NS 0-1%
1-7
1-5
2-4
3.9
4-9
3 0
2-9
7-5
2-7
3-2
Test samples with
CA. S 0-1%
3.9 (+4)
5-1 (+)
2-8 (-)
3-4 (-)
5-6 (+)
4-0 (-)
2-4 (-)
7-2 (-)
4-3 (+)
2-9 (-)
TABLE II.-Dale-Schultz Testsfor Tumour Antigen
The response of the ileum to tumour serum 0.2% after desensitization to
normal serum 0-2%. A result is rated positive (+) if more than 10% of
maximum.
Tumour type
Walker tumour in albino rats
Guinea-pig
number
1
2
3
4
5
Ehrlich ascites in BALB/c (minus) mice
Dale-Schultz response
(as % of maximum)
34 (+)
47 (+)
34 (+)
22 (+)
43 (+)
1 . 21 (4)
2 . 12, 28 (+)
3 . 27 (4)
4 . 23 (+)
Histamine-release tests.-With Walker tumour in rats, in 2 of 3 animals tested
the histamine-release in the tumour serum samples was significantly greater than
that in the control samples at the level P - 0-05. With the subcutaneous
15
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Ehrlich carcinoma, a significantly increased histamine-release with tumour serum
was obtained in 2 out of 6 animals.
Dale-Schultz tests.-Five out of 5 animals in the rat Walker tumour experiment
and 4 out of 4 in the Ehrlich ascites experiment gave positive results.
Note that the results obtained with the two different tests are not strictly
comparable as they were done on different animals and, in the case of the Ehrlich
carcinoma, differenit forms of the tumour as well.
In the second part of the study the question posed was: " When positive
results are obtained, are they specific for tumour serum? " These experiments
were carried out with strain XXIJa hepatoma in inbred C3HA mice, a trans-
plantable hepatoma in August rats and the Ehrlich carcinoma in inbred BALB/c
(minus) mice. The results obtained with tumour serum were compared with
those obtained with serum from animals with non-malignant proliferative lesions-
pneumoderma pouches or regenerating liver. The results are given in Tables
III and IV. The same guinea-pigs were used for both tests.
TABLE Ill.-Histamine-Release Testfor Tumour Antigen
Results with various test sera (0-1%) after partial desensitization to
normal serum (0.1%). Figures given are means of 3-4 samples. " NS "
= normal serum. " CA.S " = tumour serum. " Prolif. S " = serum from
animals with 2 hepatectomy. "Infl. S" - serum from animals with
pneumoderma pouches. A result is rated as positive (+) if the difference
between test samples and control samples is significant at 5%0 level on a
t-test.
Histamine-release (as % total histamine)
in:
Tumour Control Test samples with:
use(l for Guinea-pig samples c- -
sensitization niumber with: NS CA. S Prolif. S Infl. S
August rat hepatoma . . 1 . 06 0-6 () 11 () 11 -
2 . 2-6 2-7 ) 2-8 () 3-0(
3 33 1-7 ) 1-7 ) 1-9(
4 . 1-3 1L-2 ) l-2 ) 1-6(+)
StrainiXXIlahepatoma in C3HA . 1 . 46 51 ( ) 4- 7 () 4- 7
mice . . . . 2-4 2-1 ) 2-5 ) 2-7(
3 . 6-8 7-1(-) 7-5() 70(0
4 . 15-4 19-1 (+) 16-7 (-) 18-5
5 . 8-4 3-4 ) 3-5 ) 3-3(
6 . 2-1 ?-2 )- 1-9 ) 2-1(
Fhrlich ascites in BALB/c (minus) I 1- 7 2i7 (2+) 1-5 (-) 2-2 (+)
nice . . 2 2 3-6 5-1 (I) 4-2 (2 ) 6-9 (+)
3 4-2 4-4 ) 4-2 ) 4-4(
4 2 2 3 2-7 ) ° ) ' 5 2-5
5 . 0-9 1-5 (+) O-9 () O- 7
Histamine-release tests. With the August rat hepatoma no positive results
were obtained with either the tumour serum or the serum from animals with
partial hepatectomy. One out of 4 animals with pneumoderma pouches gave a
positive result. With the strain XXIIa hepatoma in C3HA mice, the tumour
serum gave a positive result in 1 animal out of 6 and no positive results were
obtained with serum from animals with pneumoderma pouches or partial hepa-
tectomies. With the Ehrlich ascites tumour 3 out of 5 animals gave positiveANAPHYLACTIC TESTS FOR TUMOUR ANTIGEN
TABLE IV. Dale-Schultz Testfor Tumour Antigent
Anaphylactic contractions of ileum wN-ith various test sera after prior
desensitization to normal serum (0X20/O). A response is rated as positive
(+) if it is more than 1000 of maximum. " Ca. S " tumour serum.
" Prolif. S " = serum from partially hepatectomized animals. "' Infl.
S " = serum from animals with pneumoderma pouches.
Dale-Schuiltz l)esponse as % of m--ax.
with:
Tumourl use(l
August rat hepatoma
Strain XXIIa hepatomia in C3HA
mice
Ehrlich ascites in BALB/c (imiinus)
inice
Guinlea-pig CA. S Prolif. S Infl. S
numnber (0 2%0) (0 2oo) (0 290)
1 4(() 2( 4) 8(
3 o0(-) 0(-))(-)
3 O(-) 0( 3
4 2(-) 0(-) (--
1 3O(-) 0( )
6 6( )(-) O(() O(-
6 .6 ( ), 8 (- O - 0 -
1 . 18 (+) 0( 8
2 . 6((),14(+6) O( 1) 23 (+) 8(
3 0 ) O( ) 12 (+),28(+)
4 (no results obtainable, ileum hyperactive)
5 (no results obtainable, ileum poorly sensi-
tized)
results with tumour serum, and 2 out of 5 gave positive results with serum from
animals with pneumoderma pouches. No positives were obtained with the
serum of animals with non-malignant proliferation of liver tissue.
Dale-Schultz tests.-With the August rat hepatoma and strain hepatoma in
C3HA mice no positive results were obtained with any of the test sera. With the
Ehrlich ascites in BALB/c (minus) mice 2 tests out of 4 with the tumour serum,
and 3 tests out of 5 with " inflammation serum " gave positive results. (Note
that one animal gave both positive and negative results with the same test sera
in different experiments.) Serum from animals with partial hepatectomies did
not give any positive results.
DISCUSSION
The results of these experiments indicate that it is possible to obtain positive
results with some tumours but not with others. The positive results are not,
however, specific for tumour serum since similar positive results were obtained in
several instances with the serum of animals with subacute inflammatory lesions.
Of the tumours used-the Walker carcinoma in albino rats, the Ehrlich
carcinoma in inbred BALB/c (minus) mice, a transplantable hepatoma in August
rats, and strain XXIJa hepatoma in inbred C3HA mice in fact only the latter
two were entirely satisfactory for the purpose. Only these two were tumours of
fairly recent origin, developed in and passaged in the same inbred strain of mice,
and could therefore be expected to be genetically identical with their hosts, (and
even in the case of these tumours there may have been some genetic drift in the
tumour or in the host strain). With the other two tumours (the Walker and
331M. MAUREEN DALE
Ehrlich tumours) some degree of genetic difference between the tumour and the
host was to be expected. It was felt, however, that even these far from ideal
tumours provided better material for test in the first instance than clinical material.
Positive results with tumour serum were obtained mainly with these allo-
geneic tumours. In the case of the Ehrlich ascites tumour in mice, 3 out of 5
histamine tests and 6 out of 8 Dale-Schultz test were positive. This was perhaps
not surprising-other immunological techniques have also given positive results
with the Ehrlich mouse ascites. Wissler et al. (1956) reported that rabbit anti-
serum against this tumour inhibited the growth ofthe ascitic form ofthe tumour in
other mice. (It is noteworthy that the antiserum was not effective against the
subcutaneous form of the tumours.) Easty and Ambrose (1957) using Ehrlich
tumour cell suspension and rabbit antisera in gel-diffusion and cytotoxic tests
found that the Ehrlich ascites tumour cells contained soluble diffusible antigens
absent from the normal kidney, spleen, liver and blood of the host strain of mice.
(These authors did not however claim that the antigens were tumour-specific.)
Takeda (1963) reported that rabbit antiserum against the Ehrlich carcinoma
when absorbed with normal mouse powder still had an inhibitory effect on anaero-
bic glycolysis of tumour cells, but after absorption with packed tumour cells, this
inhibitory effect disappeared. Bonmassar and Mariani (1962) reported positive
cytotoxic and agglutinating tests with the Ehrlich ascites tumour.
Even if non-specific positive results had not been obtained in the present
study, however, the results and those quoted above could not have been inter-
preted as necessarily indicating the presence of tumour-specific antigens because
the tumour tissue and the normal tissue were not genetically identical.
The high proportion of positive results in the tests done with the Walker
tumour was also not entirely surprising. The Walker tumour was grown in
random-bred albino rats and here again there were genetic differences between
tumour and host. Positive results obtained with tumour serum after desensiti-
zation to normal serum could be due to these differences. Another possible
explanation is that there is an increase in concentration of a normal serum con-
stituent. Darcy (1955, 1960) using gel-diffusion techniques, found high con-
centrations of ac-globulin in the serum of rats with Walker tumours. The a-
globulin was present in normal serum but was increased 15-fold in tumour growth.
An increase in concentration of a normal serum constituent of this magnitude
could also account for the positive results obtained with anaphylactic tests in the
present study because, as was pointed out in a previous paper (Dale, 1965b), if one
of the main antigens of the " desensitizing " solution is present in increased con-
centration in the challenging solution, a further positive response to that antigen
can be obtained. Darcy found that theac-globulin was also present in the serum of
rats with actively growing tissue, (regenerating liver, kidney or skin) and in preg-
nant females. These finds were confirmed by Campbell, Kernot and Roitt (1959).
In clinical studies employing physico-chemical methods non-specific changes in
mucoproteins in neoplastic infections and other conditions have been described
(Winzler, 1953; Lockey, Anderson and Maclagan, 1956) and it may be possible
that something of the same sort occurred here. The positive results obtained in
the present study with serum from animals with pneumoderma pouches may be
another example of the same non-specific serum change. Although if the positive
results with tumour serum and " inflammation serum " are due to a phenomenon
similar to that described by Darcy, and by Campbell et al. it is surprising that the
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sera from animals with partial hepatectomies were consistently negative in all
three groups of animals in which it was tested.
The negative results obtained with the mouse hepatoma were of particular
interest as this was one experiment in which specific positive results might have
provided suggestive evidence of the existence of tumour antigens. As it is, there
was only 1 positive histamine-release test in 6 and no positive Dale-Schultz tests.
This is all the more surprising when the findings of Abelev et al. (1963) with this
same tumour are considered. Using gel-diffusion and immuno-electrophoresis
these authors showed that an a-globulin, not present in normal mouse liver or
serum (though present in the embryonic mouse) was formed by the tumour and
was present in the serum of tumour-bearing mice. This substance, though
apparently readily detectable by double-diffusion in gel and immuno-electro-
phoresis was not detected by the supposedly more sensitive anaphylactic tests.
The results obtained in this study are at variance with those obtained with
rabbit tumours by Shevliaguin (1959) who, using guinea-pigs sensitized with
Brown-Pearce carcinoma extracts obtained positive anaphylactic responses with
the serum from rabbits with Brown-Pearce carcinomata and negative results
with the serum of rabbits with non-malignant conditions such as Shope papillo-
mata, acute inflammation with necrosis, etc. Shevliaguin did not, however,
interpret his results as necessarily indicating the presence of a specific tumour
antigen. In fact in a subsequent study he reported positive results with tumour
serum in guinea-pigs sensitized with normal tissue extracts (1961).
SUMMARY
Anaphylactic tests for tumour antigen gave positive results in some animal
tumours, but the results were not specific for neoplasia.
I am indebted to Professor H. 0. Schild and Dr. J. L. Mongar for valuable
discussion and advice. This work was supported by a grant from the British
Empire Cancer Campaign for Research.
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